Outcomes, risk of other malignancies, and need for formal mapping procedures in patients with perianal Bowen's disease: Invited commentary

Diseases of the Colon and Rectum

Volumn 47, Issue 10, 2004, Pages 1660-1661

  Gottesman, Lester ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

BOWEN DISEASE; CANCER RECURRENCE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; COST; EXCISION; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NOTE; PREOPERATIVE EVALUATION; RECTUM BIOPSY; RETROSPECTIVE STUDY; SPLIT THICKNESS SKIN GRAFT; VULVA CANCER;

EID: 4944263631     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (6)

1. Bowen JT. Precancerous dermatosis: a study of two cases of chronic atypical epithelial proliferation. J Cutan Dis 1912;30:241-5.
2. Graham JH, Kelwig EB. Bowen's disease and its relationship to systemic cancer. Arch Dermatol 1961;83:738.
3. Chute CG, Chuang T, Bergstalih EJ, Su W. The subsequent risk of internal cancer with Bowen's disease. A population based study. JAMA 1991;266:816.
4. Strauss RJ, Fazio VW. Bowen's disease of the anal and perianal area: a report and analysis of twelve cases. Am J Surg 1979;137:231-4.
5. Nouri K, O'Connell C, Rivas MP. Imiquimod for the treatment of Bowen's disease and invasive squamous cell cancer. J Drugs Dermatol 2003;2:669-73.
6. Chen K, Shumack S. Treatment of Bowen's disease using a cycle regimen of Imiquimod 5% cream. Clin Exp Dermatol 2003;28:10-2.